JPWO2019038384A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019038384A5
JPWO2019038384A5 JP2020510099A JP2020510099A JPWO2019038384A5 JP WO2019038384 A5 JPWO2019038384 A5 JP WO2019038384A5 JP 2020510099 A JP2020510099 A JP 2020510099A JP 2020510099 A JP2020510099 A JP 2020510099A JP WO2019038384 A5 JPWO2019038384 A5 JP WO2019038384A5
Authority
JP
Japan
Prior art keywords
pyridin
pyrrolo
trifluoromethyl
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020510099A
Other languages
English (en)
Japanese (ja)
Other versions
JP7199738B2 (ja
JP2020531487A (ja
JP2020531487A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2018/072785 external-priority patent/WO2019038384A1/en
Publication of JP2020531487A publication Critical patent/JP2020531487A/ja
Publication of JPWO2019038384A5 publication Critical patent/JPWO2019038384A5/ja
Publication of JP2020531487A5 publication Critical patent/JP2020531487A5/ja
Priority to JP2022198545A priority Critical patent/JP2023021277A/ja
Application granted granted Critical
Publication of JP7199738B2 publication Critical patent/JP7199738B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020510099A 2017-08-23 2018-08-23 アザインドリルピリドンおよびジアザインドリルピリドン化合物 Active JP7199738B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022198545A JP2023021277A (ja) 2017-08-23 2022-12-13 アザインドリルピリドンおよびジアザインドリルピリドン化合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17187519.8 2017-08-23
EP17187519 2017-08-23
PCT/EP2018/072785 WO2019038384A1 (en) 2017-08-23 2018-08-23 AZAINDOLYLPYRIDONE AND DIAZAINDOLYLPYRIDONE COMPOUNDS

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022198545A Division JP2023021277A (ja) 2017-08-23 2022-12-13 アザインドリルピリドンおよびジアザインドリルピリドン化合物

Publications (4)

Publication Number Publication Date
JP2020531487A JP2020531487A (ja) 2020-11-05
JPWO2019038384A5 true JPWO2019038384A5 (https=) 2022-10-20
JP2020531487A5 JP2020531487A5 (https=) 2022-10-20
JP7199738B2 JP7199738B2 (ja) 2023-01-06

Family

ID=59686871

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020510099A Active JP7199738B2 (ja) 2017-08-23 2018-08-23 アザインドリルピリドンおよびジアザインドリルピリドン化合物
JP2022198545A Ceased JP2023021277A (ja) 2017-08-23 2022-12-13 アザインドリルピリドンおよびジアザインドリルピリドン化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022198545A Ceased JP2023021277A (ja) 2017-08-23 2022-12-13 アザインドリルピリドンおよびジアザインドリルピリドン化合物

Country Status (20)

Country Link
US (2) US11498919B2 (https=)
EP (2) EP3672967B1 (https=)
JP (2) JP7199738B2 (https=)
KR (1) KR102731945B1 (https=)
CN (3) CN116589461A (https=)
AU (1) AU2018321135B2 (https=)
CY (1) CY1124818T1 (https=)
DK (1) DK3672967T3 (https=)
ES (1) ES2902346T3 (https=)
HR (1) HRP20211999T1 (https=)
HU (1) HUE057818T2 (https=)
IL (3) IL302355A (https=)
LT (1) LT3672967T (https=)
PL (1) PL3672967T3 (https=)
PT (1) PT3672967T (https=)
RS (1) RS62785B1 (https=)
SI (1) SI3672967T1 (https=)
SM (1) SMT202100718T1 (https=)
TW (2) TW202325708A (https=)
WO (1) WO2019038384A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7199738B2 (ja) * 2017-08-23 2023-01-06 スプリント バイオサイエンス アクティエボラーグ アザインドリルピリドンおよびジアザインドリルピリドン化合物
CA3200038A1 (en) * 2020-11-25 2022-06-02 Deciphera Pharmaceuticals, Llc Anti-viral activity of vps34 inhibitors
WO2022115562A1 (en) 2020-11-25 2022-06-02 Deciphera Pharmaceuticals, Llc Morpholino derivatives as vsp34 inhibitors for use in the treatment of a viral infection

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1154024B (it) * 1982-09-22 1987-01-21 Lepetit Spa Derivati pridinici e procedimento per la loro produzione
WO2006127587A1 (en) 2005-05-20 2006-11-30 Vertex Pharmaceuticals Incorporated Pyrrolopyridines useful as inhibitors of protein kinase
CN102143746A (zh) * 2008-07-03 2011-08-03 埃克塞利希斯股份有限公司 Cdk 调节剂
CA2795422A1 (en) * 2010-04-19 2011-10-27 Abbvie Inc. Pyrrolopyridine inhibitors of kinases
AU2011346567A1 (en) 2010-12-21 2013-07-25 Novartis Ag Bi-heteroaryl compounds as Vps34 inhibitors
DK2655375T3 (en) 2010-12-23 2015-03-09 Sanofi Sa PYRIMIDINON DERIVATIVES, PREPARATION AND PHARMACEUTICAL USE THEREOF
GB201120317D0 (en) 2011-11-24 2012-01-04 Queen Mary & Westfield College Screening method
CN103450152B (zh) 2012-06-04 2015-11-18 济南海乐医药技术开发有限公司 基于吲唑、吲哚或氮杂吲唑、氮杂吲哚的双芳基脲类结构抗肿瘤药物
FR2992314B1 (fr) 2012-06-22 2015-10-16 Sanofi Sa Nouveaux derives de 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one et 1,2,3,4-tetrahydro-pyrimido{1,2-a}pyrimidin-6-one comportant une morpholine substituee, leur preparation et leur utilisation pharmaceutique
AU2015206652A1 (en) 2014-01-14 2016-08-04 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
WO2015108881A1 (en) * 2014-01-14 2015-07-23 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
MA39823A (fr) 2014-04-03 2018-01-09 Janssen Pharmaceutica Nv Dérivés de pyridine macrocyclique
MA39822A (fr) 2014-04-03 2018-02-06 Janssen Pharmaceutica Nv Dérivés de pyrimidine bicycle
AU2017219846B2 (en) 2016-02-19 2021-05-13 Sprint Bioscience Ab 6-aryl-4-morpholin-1-ylpyridone compounds useful for the treatment of cancer and diabetes
DK3416957T3 (da) 2016-02-19 2020-09-21 Sprint Bioscience Ab 6-heterocyclyl-4-morpholin-4-ylpyridin-2-on-forbindelser anvendelige ved behandlingen af cancer og diabetes
JP7199738B2 (ja) * 2017-08-23 2023-01-06 スプリント バイオサイエンス アクティエボラーグ アザインドリルピリドンおよびジアザインドリルピリドン化合物

Similar Documents

Publication Publication Date Title
US11643408B2 (en) N-pyridinyl acetamide derivatives as inhibitors of the WNT signaling pathway
JP6162144B2 (ja) 4,4−二置換−1,4−ジヒドロピリミジン、及びb型肝炎の処置のための医薬としてのその使用
CA2515197A1 (en) Pyrazolopyridine derivates
JP2020531488A5 (https=)
JP2013523884A5 (https=)
JP7201260B2 (ja) ピリジンアミン-ピリドンおよびピリミジンアミン-ピリドン化合物
RU2018131766A (ru) 6-гетероциклил-4-морфолин-4-илпиридин-2-оны, пригодные для лечения рака и диабета
JP2019505595A5 (https=)
JP2010512338A5 (https=)
JP2012525395A5 (https=)
HRP20192151T1 (hr) Derivati izokromena kao inhibitori fosfoinozitid 3-kinaza
JP2019505594A5 (https=)
RU2018131775A (ru) 6-арил-4-морфолин-1-илпиридоны, пригодные для лечения рака или диабета
JP2021523177A5 (https=)
JP2020523309A5 (https=)
JP2023021277A5 (https=)
JP2023021277A (ja) アザインドリルピリドンおよびジアザインドリルピリドン化合物
JPWO2019038384A5 (https=)
JP2020531485A5 (https=)
JPWO2019215316A5 (https=)
JPWO2022147092A5 (https=)
JPWO2019038387A5 (https=)
RU2023101189A (ru) Азаиндолилпиридоны и диазаиндолилпиридоны
JPWO2023019259A5 (https=)
RU2024118799A (ru) Пиримидины и способы их применения